Dow Down 0.22% Nasdaq Up 0.14%

Vermillion, Inc. (VRML)

-NasdaqCM
2.22 Up 0.02(1.13%) Aug 22, 3:57PM EDT
Prev Close:2.19
Open:2.18
Bid:2.17 x 400
Ask:2.21 x 700
1y Target Est:4.00
Beta:1.92
Earnings Date:Nov 12 - Nov 17 (Est.)
Day's Range:2.14 - 2.23
52wk Range:1.50 - 3.83
Volume:11,963
Avg Vol (3m):41,970
Market Cap:79.66M
P/E (ttm):N/A
EPS (ttm):-0.39
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for VRML

Comparison

Symbol% ChgMkt Cap
VRMLUp 1.13%79.66M
ABTDown 0.50%63.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :N/A
Quarterly EPS Est (Jun-13) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vermillion, Inc., together with its subsidiaries, is engaged in the discovery, development, and commercialization of diagnostic tests that help physicians diagnose, treat, and enhance outcomes for patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback